289044-51-5

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 289043-41-0 {(S)-1-[2-(4-Cyclopentylmethoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester 
• 289043-37-4 {(S)-1-[2-(4-Isobutoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester 
• 596120-13-7 (2-tert-butoxycarbonylamino-ethyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-carbamic acid tert-butyl ester 
• 596120-15-9 (2-tert-butoxycarbonylamino-ethyl)-(4-cyclohexyloxy-phenyl)-carbamic acid tert-butyl ester 
• 596120-19-3 (2-tert-butoxycarbonylamino-ethyl)-[4-(1-methyl-piperidin-4-yloxy)-phenyl]-carbamic acid tert-butyl ester 
• 596120-16-0 (2-tert-butoxycarbonylamino-ethyl)-(4-cyclopentylmethoxy-phenyl)-carbamic acid tert-butyl ester 
• 596120-18-2 (2-tert-butoxycarbonylamino-ethyl)-[4-(tetrahydro-pyran-4-yloxy)-phenyl]-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K - Investigating P1′ substituents

Modeling, synthesis and in vitro activities of a series of arylaminoethyl amide based inhibitors of the cysteine protease cathepsin K are described.